Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Fredag 17 Juli | 06:37:45 Europe / Stockholm

Svenska | English

Västra Hamnen Market Focus

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Gabather: TOTEMS-study delayed, not derailed

2025-09-01 12:00:00

Issues with clinical test material delays TOTEMS-study
New chairman elected at the AGM
We keep our fair value of SEK 0.092 per share

Before releasing its Q2 2025 report, Gabather announced that the TOTEMS-study would be delayed due to issues with the clinical trial material. Meanwhile, changes have taken place in the company’s board, with a new chairman being elected. Despite challenges, we maintain our fair value of SEK 0,092 per share.

The full report is available here.